Phillip B. Donenberg's Net Worth
$2.52 Million
Who is Phillip B. Donenberg?
Phillip B. Donenberg has an estimated net worth of $2.52 Million. This is based on reported shares across multiple companies, which include Taysha Gene Therapies, Inc., RestorGenex Corp, BIOSANTE PHARMACEUTICALS INC, AVROBIO, Inc., AveXis, Inc., and DEPOMED INC.
SEC CIK
Phillip B. Donenberg's CIK is 0001238120
Past Insider Trading and Trends
2011 was Phillip B. Donenberg's most active year for acquiring shares with 5 total transactions. Phillip B. Donenberg's most active month to acquire stocks was the month of May. 2018 was Phillip B. Donenberg's most active year for disposing of shares, totalling 5 transactions. Phillip B. Donenberg's most active month to dispose stocks was the month of April. 2004 saw Phillip B. Donenberg paying a total of $166,248.60 for 79,166 shares, this is the most they've acquired in one year. In 2004 Phillip B. Donenberg cashed out on 79,166 shares for a total of $166,248.60, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Taysha Gene Therapies, Inc. (TSHA) Snapshot price: $1.66
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +43.13% | 49.22K |
—
|
—
| 163.33K |
May 29
| |||
Form 4
| +3,703.70% | 111.11K |
$0.90 | $99,999.90 | 114.11K |
Aug 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
∞
| 3K |
$7.78 | $23,340.00 | 3K |
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
RestorGenex Corp (CRVO) Snapshot price: $9.08
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BIOSANTE PHARMACEUTICALS INC (ANIP) Snapshot price: $56.23
Sr VP Finance, CFO, Secy
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
| +2.31% | 1K |
$2.23 | $2,230.00 | 44.32K |
Aug 8
| |||
Form 4
| +2.36% | 1K |
$2.19 | $2,190.00 | 43.32K |
Aug 5
| |||
Form 4
| +2.42% | 1K |
$1.88 | $1,880.00 | 42.32K |
Jan 21
| |||
Form 4
| +2.48% | 1K |
$1.88 | $1,879.90 | 41.32K |
Jan 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 4
| +8.04% | 3K |
$1.00 | $3,000.00 | 40.32K |
Dec 31
| |||
Form 4
| +1.36% | 500 |
$2.15 | $1,075.00 | 37.32K |
Jul 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 15
| |||
Form 4
| +2.79% | 1K |
$3.76 | $3,755.00 | 36.82K |
Dec 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 12
| |||
Form 4
| +2.87% | 1K |
$1.95 | $1,949.00 | 35.82K |
Jul 20
| |||
Form 4
| +149.19% | 20.85K |
$3.07 | $0.20 | 34.82K |
Mar 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 16
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jul 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 22
| |||
Form 4
| +7.71% | 1K |
$2.15 | $2,150.00 | 13.97K |
Aug 4
| |||
| No matching records found | |||||||||
Tectonic Therapeutic, Inc. (AVRO) Snapshot price: $1.3
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
∞
| 2K |
$11.71 | $23,420.00 | 2K |
Feb 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AveXis, Inc. No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.8K |
—
|
—
| 3.8K |
May 15
| |||
Form 4
|
∞
| 3.8K |
—
|
—
| 3.8K |
Mar 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||